The KPH Healthcare Services suit is new to me - another BS suit filed for anti-competitive practices about API supply - another insurer that basically says in writing that they want to bypass R-IT IP and use GV for that patent protected indication:
As a result of Amarin’s alleged anticompetitive conduct,
KPH paid supra-competitive prices for its Vascepa purchases and KPH was injured by the illegal
conduct alleged herein. Absent the unlawful conduct alleged herein, KPH would have purchased
less expensive generic alternatives, rather than branded Vascepa.
Don't know what happens to these harassing suits - payback for AMRN suing HealthNet? SC denied cert, so AMRN is SOL on the legal front, all avenues have been exhausted.